Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study points to new gene therapy tool in preventing epileptic seizures

25.07.2003


A new study by gene therapy scientists at the University of North Carolina at Chapel Hill may lead to an effective long-term treatment for preventing seizures associated with a common form of epilepsy. The study appears this week in the Internet edition of the journal Nature Medicine and will appear in the Aug. 1 print edition of the journal. The research provides an important foundation for the development of new gene therapies to treat focal seizure disorders, the authors said.



As the name indicates, focal (or partial) seizures involve an electrical storm affecting only a part of the brain. Such seizures may remain localized or spread to other parts of the cerebral cortex. The temporal lobes, one on each side of the head just above the ears, are the brain sites of one of the most common forms of epilepsy involving focal seizures.

"Epilepsy afflicts approximately 1 percent of the U.S. population. A large proportion of epileptic adults have temporal lobe epilepsy, which is often very difficult to treat, and for about 30 percent of those individuals the only treatment option is surgery," said study co-author Dr. Thomas J. McCown, associate professor of psychiatry in UNC’s School of Medicine and a member of the UNC Gene Therapy Center. That option is surgical resection, or removal of abnormal brain tissue at the site linked to the seizures. However, despite resection, only 50 percent to 60 percent of temporal lobe epilepsy patients improve following the surgery.


In the new research, McCown and his Gene Therapy Center colleagues Rebecca Haberman, a post-doctoral fellow, and Dr. R. Jude Samulski, center director and professor of pharmacology, used a novel strategy to make laboratory rats less sensitive to experimentally induced focal seizures.

The researchers used an altered adeno-associated virus, or AAV, to deliver into the animals’ brain cells a coded sequence for the production of galanin, a neuroactive peptide known to suppress seizure activity.

In earlier studies, McCown and his team learned there would be no attenuation of seizure activity if galanin was produced within neurons and wasn’t secreted from the cells. In addition, brain cells would die following induced seizures. Moreover, these cells were in a brain area intimately involved in temporal lobe epilepsy, McCown said.

In the new research, the cargo delivered via AAV included coded instructions for galanin and a secretory sequence that caused the galanin to be non-specifically secreted from the cell. In one experiment, sensitivity to focal seizure was reduced significantly. In another model seizure experiment, the AAV "construct" was delivered to only one side of the brain. Cell death after seizure induction occurred only in the untreated area.

"The treated side looked normal," McCown said. "This suggests that we can secrete an active peptide in a brain structure that’s closely tied to temporal lobe seizures."

Gene expression following delivery the AAV construct can be turned off by the antibiotic doxycycline, which McCown said was an important feature of the research. "Whether it be via an antimicrobial compound or an analog, this is an absolutely crucial component to human gene therapy. You have to be able to turn gene expression off."

In terms of focal seizure control through gene therapy, the new study brings researchers a step closer to resolving a major issue: how to influence only a specific area of the brain. "In the case of seizures, the area is much more restrictive than that of a single-gene disorder where you need to hit most of the cells in a large proportion of the brain," McCown said.

Further laboratory studies with this new gene therapy platform may prove promising for treatment of temporal lobe epilepsy patients who are slated for surgery, McCown said. "You could put in this AAV vector prior to surgery and then see what effect it has on the tissue to be removed. If it controls seizure activity, you might have to reconsider resection."

Contact: Mc Cown at +1-919-966-3081, thomas_mccown@med.unc.edu

Leslie Lang | EurekAlert!
Further information:
http://www.med.unc.edu

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>